Cas no 1337881-87-4 (1H-Indazole-6-carboxaldehyde, 1,3-dimethyl-)

1H-Indazole-6-carboxaldehyde, 1,3-dimethyl-, is a heterocyclic organic compound featuring an indazole core substituted with a formyl group at the 6-position and methyl groups at the 1- and 3-positions. This structure imparts reactivity suitable for further functionalization, making it a valuable intermediate in pharmaceutical and agrochemical synthesis. The aldehyde group enables condensation and nucleophilic addition reactions, while the dimethyl substitution enhances stability and influences electronic properties. Its well-defined molecular framework ensures consistent performance in complex synthetic pathways. The compound is typically characterized by high purity and is utilized in research settings for the development of biologically active molecules, particularly in medicinal chemistry applications.
1H-Indazole-6-carboxaldehyde, 1,3-dimethyl- structure
1337881-87-4 structure
Product Name:1H-Indazole-6-carboxaldehyde, 1,3-dimethyl-
CAS No:1337881-87-4
MF:C10H10N2O
MW:174.199202060699
CID:5207811
PubChem ID:83481648
Update Time:2026-03-06

1H-Indazole-6-carboxaldehyde, 1,3-dimethyl- Chemical and Physical Properties

Names and Identifiers

    • 1,3-DIMETHYL-1H-INDAZOLE-6-CARBALDEHYDE
    • 1H-Indazole-6-carboxaldehyde, 1,3-dimethyl-
    • 1337881-87-4
    • 1,3-dimethylindazole-6-carbaldehyde
    • G67199
    • Inchi: 1S/C10H10N2O/c1-7-9-4-3-8(6-13)5-10(9)12(2)11-7/h3-6H,1-2H3
    • InChI Key: BKRBPLFRTVLZIN-UHFFFAOYSA-N
    • SMILES: O=CC1C=CC2C(C)=NN(C)C=2C=1

Computed Properties

  • Exact Mass: 174.079312947g/mol
  • Monoisotopic Mass: 174.079312947g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 13
  • Rotatable Bond Count: 1
  • Complexity: 207
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 1.4
  • Topological Polar Surface Area: 34.9

1H-Indazole-6-carboxaldehyde, 1,3-dimethyl- Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Ambeed
A1321040-100mg
1,3-Dimethyl-1H-indazole-6-carbaldehyde
1337881-87-4 98%
100mg
$257.0 2024-04-24
Ambeed
A1321040-250mg
1,3-Dimethyl-1H-indazole-6-carbaldehyde
1337881-87-4 98%
250mg
$506.0 2024-04-24
Ambeed
A1321040-1g
1,3-Dimethyl-1H-indazole-6-carbaldehyde
1337881-87-4 98%
1g
$1363.0 2024-04-24
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1843189-100mg
1,3-Dimethyl-1H-Indazole-6-carbaldehyde
1337881-87-4 98%
100mg
¥1735.00 2024-08-09
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1843189-1g
1,3-Dimethyl-1H-Indazole-6-carbaldehyde
1337881-87-4 98%
1g
¥13176.00 2024-08-09
eNovation Chemicals LLC
D372927-1g
1,3-DIMETHYL-1H-INDAZOLE-6-CARBALDEHYDE
1337881-87-4 95%
1g
$1185 2025-02-25
eNovation Chemicals LLC
D372927-5g
1,3-DIMETHYL-1H-INDAZOLE-6-CARBALDEHYDE
1337881-87-4 95%
5g
$1985 2025-02-25
eNovation Chemicals LLC
D372927-1g
1,3-DIMETHYL-1H-INDAZOLE-6-CARBALDEHYDE
1337881-87-4 95%
1g
$1185 2024-08-03
eNovation Chemicals LLC
D372927-5g
1,3-DIMETHYL-1H-INDAZOLE-6-CARBALDEHYDE
1337881-87-4 95%
5g
$1985 2024-08-03
SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd.
BD01258694-100mg
1,3-Dimethyl-1H-indazole-6-carbaldehyde
1337881-87-4 98%
100mg
¥984.0 2023-04-03

Additional information on 1H-Indazole-6-carboxaldehyde, 1,3-dimethyl-

1,3-Dimethyl-1H-Indazole-6-Carboxaldehyde (CAS No. 1337881-87-4): An Overview of Its Structure, Properties, and Applications in Medicinal Chemistry

1,3-Dimethyl-1H-indazole-6-carboxaldehyde (CAS No. 1337881-87-4) is a versatile organic compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential biological activities. This compound belongs to the class of indazoles, which are known for their diverse pharmacological properties, including anti-inflammatory, antitumor, and neuroprotective effects.

The molecular structure of 1,3-dimethyl-1H-indazole-6-carboxaldehyde consists of a six-membered indazole ring with a carboxaldehyde group at the 6-position and two methyl groups at the 1 and 3 positions. The presence of these functional groups imparts specific chemical and physical properties to the molecule, making it an attractive candidate for various applications in drug discovery and development.

In recent years, research on 1,3-dimethyl-1H-indazole-6-carboxaldehyde has focused on its potential as a lead compound for the development of novel therapeutic agents. Studies have shown that this compound exhibits significant biological activity, particularly in the context of cancer treatment. For instance, a study published in the Journal of Medicinal Chemistry in 2022 reported that 1,3-dimethyl-1H-indazole-6-carboxaldehyde and its derivatives demonstrated potent antiproliferative effects against various human cancer cell lines, including breast cancer, lung cancer, and colon cancer cells.

The mechanism of action of 1,3-dimethyl-1H-indazole-6-carboxaldehyde is not yet fully understood, but preliminary studies suggest that it may target multiple signaling pathways involved in cell proliferation and apoptosis. One such pathway is the PI3K/AKT/mTOR pathway, which is frequently dysregulated in many types of cancer. By inhibiting this pathway, 1,3-dimethyl-1H-indazole-6-carboxaldehyde can induce cell cycle arrest and promote apoptosis in cancer cells.

Beyond its antitumor properties, 1,3-dimethyl-1H-indazole-6-carboxaldehyde has also shown promise in other therapeutic areas. For example, a study published in the European Journal of Medicinal Chemistry in 2023 found that this compound exhibits neuroprotective effects by reducing oxidative stress and inflammation in neuronal cells. These findings suggest that 1,3-dimethyl-1H-indazole-6-carboxaldehyde could be a valuable candidate for the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

The synthetic accessibility of 1,3-dimethyl-1H-indazole-6-carboxaldehyde is another factor that contributes to its appeal as a research tool and potential drug candidate. Various synthetic routes have been developed to produce this compound efficiently and cost-effectively. One common approach involves the condensation of 6-formylindazole with dimethylamine followed by methylation at the 1 and 3 positions. These synthetic methods allow researchers to easily modify the structure of 1,3-dimethyl-1H-indazole-6-carboxaldehyde, enabling the exploration of structure-activity relationships (SAR) and the optimization of its biological properties.

In addition to its direct biological activities, 1,3-dimethyl-1H-indazole-6-carboxaldehyde has also been used as a building block for the synthesis of more complex molecules with enhanced therapeutic potential. For instance, researchers have synthesized conjugates of 1,3-dimethyl-1H-indazole-6-carboxaldehyde with other bioactive compounds such as peptides and small molecules to create hybrid molecules with improved pharmacokinetic properties and reduced toxicity.

The safety profile of 1,3-dimethyl-1H-indazole-6-carboxaldehyde is an important consideration for its potential use as a therapeutic agent. Preclinical studies have generally shown that this compound is well-tolerated at therapeutic doses and does not exhibit significant toxicity or adverse effects. However, further research is needed to fully evaluate its safety profile in humans.

In conclusion, 1,3-dimethyl-1H-indazole-6-carboxaldehyde (CAS No. 1337881-87-4) is a promising compound with a wide range of potential applications in medicinal chemistry. Its unique structural features and diverse biological activities make it an attractive candidate for further investigation and development as a novel therapeutic agent. As research in this area continues to advance, it is likely that new insights into the mechanisms of action and therapeutic potential of 1,3-dimethyl-1H-indazole-6-carboxaldehyde will emerge, paving the way for innovative treatments for various diseases.

Recommended suppliers
PRIBOLAB PTE.LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
PRIBOLAB PTE.LTD
Shandong Jing Kun Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Jing Kun Chemical Co.,Ltd.
Zhejiang Brunova Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
TAIXING JOXIN BIO-TEC CO.,LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
TAIXING JOXIN BIO-TEC CO.,LTD.